Connor Blankenship, PhD
About Connor Blankenship, PhD
Connor Blankenship, PhD, is a scientist specializing in mammalian synthetic biology, currently employed at Nabla Bio, Inc. in Cambridge, Massachusetts. He has a background in pharmaceutical sciences and chemical engineering, with extensive experience in enzymology and protein engineering.
Current Role at Nabla Bio
Connor Blankenship serves as a Scientist in Mammalian Synthetic Biology at Nabla Bio, Inc. since 2023. In this role, he focuses on advancing synthetic biology applications and developing innovative biological platforms. His work contributes to the company's mission of leveraging biotechnology to address significant challenges in the field.
Previous Experience at University of Michigan
Connor Blankenship worked at the University of Michigan as a Research Assistant from 2013 to 2017. During this four-year period, he gained valuable experience in research methodologies and laboratory practices. His role involved supporting various projects that contributed to the understanding of chemical engineering principles.
Education and Expertise in Pharmaceutical Sciences
Connor Blankenship earned his Doctor of Philosophy (PhD) in Pharmaceutical Sciences from the University of Wisconsin-Madison, where he studied from 2017 to 2023. His doctoral research focused on synthetic biology and protein therapeutics, equipping him with extensive knowledge in these areas. He also holds a Bachelor's Degree in Chemical Engineering from the University of Michigan, obtained from 2013 to 2017.
Research Background in Enzymology and Biochemistry
Connor Blankenship has a strong background in enzymology, biochemistry, protein engineering, and cell biology. His research includes a focus on functionally dissecting protein-protein interaction modes of O-GlcNAc transferase both in vitro and in cellular environments. This expertise supports his interests in synthetic biology and next-generation biological platform development.
Motivation and Career Aspirations
Connor Blankenship is motivated to tackle significant questions in biotechnology. He seeks opportunities to work in early-stage biotech startups, aiming to collaborate with highly motivated scientists. His career aspirations align with his interests in advancing the field of synthetic biology and contributing to innovative solutions.